Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Nociceptive

NT has been impHcated in neuroendocrine function, thermal and circadian regulation, cardiovascular and digestive system function, nociception, and in psychoses as a DA modulator. [Pg.563]

Dynorphin may also influence nociception at the spinal level. The levels of prodynorphin mRNA and immunoreactive dynorphin increase in the chronic inflammatory arthritic model (158). Dynorphin also inhibits morphine or P-endorphin-induced analgesia in naive animals and enhances analgesia in tolerant animals, indicating that this peptide may have a regulatory role in opioid analgesia (159). This effect does not appear to be mediated by a classical opioid receptor, since des-tyrosine dynorphin, which does not bind to opioid receptors, also antagonizes morphine analgesia (160). [Pg.450]

Numerous neuropeptides are beheved to be involved with the transmission or inhibition of pain, and the hope is to utilize this approach as a strategy to induce analgesia. Substance P is reported to be a transmitter of nociceptive impulses (39), and therefore antagonists should be analgesic. Capsaicin [404-86-4], C2gH2yN02, is known to deplete substance P and cause analgesia (40), but its side effects are intolerable. Antagonists to bradykinin [58-82-2], a substance known to induce pain (41), have shown some success in preclinical trials. [Pg.385]

Adenosine is produced by many tissues, mainly as a byproduct of ATP breakdown. It is released from neurons, glia and other cells, possibly through the operation of the membrane transport system. Its rate of production varies with the functional state of the tissue and it may play a role as an autocrine or paracrine mediator (e.g. controlling blood flow). The uptake of adenosine is blocked by dipyridamole, which has vasodilatory effects. The effects of adenosine are mediated by a group of G protein-coupled receptors (the Gi/o-coupled Ai- and A3 receptors, and the Gs-coupled A2a-/A2B receptors). Ai receptors can mediate vasoconstriction, block of cardiac atrioventricular conduction and reduction of force of contraction, bronchoconstriction, and inhibition of neurotransmitter release. A2 receptors mediate vasodilatation and are involved in the stimulation of nociceptive afferent neurons. A3 receptors mediate the release of mediators from mast cells. Methylxanthines (e.g. caffeine) function as antagonists of Ai and A2 receptors. Adenosine itself is used to terminate supraventricular tachycardia by intravenous bolus injection. [Pg.19]

Analgesics interfere with the generation and/or transmission of impulses following noxious stimulation ( nociception) in the nervous system. This can occur at peripheral and/or central levels of the neuraxis. The therapeutic aim is to diminish the perception of pain. [Pg.75]

Neurotrophic Factors Pain and Nociception Antidepressant Dtugs... [Pg.251]

Causalgia is burning pain evoked by the activation of sympathetic efferent fibres. The likely mechanism underlying this syndrome involves ectopic expression of a-adrenoceptors on nociceptive afferents following peripheral injury or disease. [Pg.339]

Endothelins comprise a family of three vasoactive isopeptides of 21 amino acids that have an essential role in the regulation of the vascular and bronchiolar tone and the control of natriuresis in the kidney. Endothelin peptides are also involved in nociception and have a critical role in the progression of prostate and ovarian cancer. [Pg.470]

GABAb receptors mediate the slow and prolonged physiological effects of the inhibitory neurotransmitter GABA. Functional GABAb receptors are comprised of two subunits, GABAbR1 and GABAbR2. Both subunits are G-protein-coupled receptors, which couple to the Gi/o family and are densely expressed at spinal nociceptive synapses. [Pg.515]

G-protein-coupled Receptors Pain and Nociception Analgesics... [Pg.552]

Mice that are homozygous for a disrupted Bx or B2 receptor gene are healthy, fertile and normotensive. In Bx-deficient mice, bacterial lipopolysaccharide-induced hypotension is diminished and the recruitment of polymorphonuclear leukocytes to the sites of tissue injury is impaired, and the animals show signs of hypoalgesia. Deletion of the B2 gene in mice leads to salt-sensitive hypertension and altered nociception. [Pg.675]

The locus cemleus is important for the regulation of attentional states and autonomic nervous system activity. It has also been implicated in the autonomic and stress-like effects of opiate withdrawal. A noradrenergic pathway originating from the locus cemleus which descends into the spinal cord is part of the descending inhibitory control system, which has an inhibitory effect on nociceptive transmission in the dorsal horn. [Pg.704]

Analgesics Local Anaesthetics Voltage-dependent Na+Channels Pain and Nociception... [Pg.829]

The neuropeptides are peptides acting as neurotransmitters. Some form families such as the tachykinin family with substance P, neurokinin A and neurokinin B, which consist of 11 or 12 amino acids and possess the common carboxy-terminal sequence Phe-X-Gly-Leu-Met-CONH2. Substance P is a transmitter of primary afferent nociceptive neurones. The opioid peptide family is characterized by the C-terminal sequence Tyr-Gly-Gly-Phe-X. Its numerous members are transmitters in many brain neurones. Neuropeptide Y (NPY), with 36 amino acids, is a transmitter (with noradrenaline and ATP) of postganglionic sympathetic neurones. [Pg.831]

Historically ganglionic nAChR have been targets for treating hypertension. The discovery of a large family of nAChR subtypes in the CNS, coupled with observations that nicotine has anti-nociceptive, neuro-protective and cognitive effects, has led to the recognition that neuronal nAChR are potential targets... [Pg.853]

Nociception is the normal experience of pain in healthy people. [Pg.868]


See other pages where Nociceptive is mentioned: [Pg.685]    [Pg.532]    [Pg.549]    [Pg.450]    [Pg.171]    [Pg.171]    [Pg.178]    [Pg.65]    [Pg.65]    [Pg.76]    [Pg.320]    [Pg.321]    [Pg.339]    [Pg.387]    [Pg.421]    [Pg.421]    [Pg.503]    [Pg.515]    [Pg.520]    [Pg.521]    [Pg.522]    [Pg.552]    [Pg.606]    [Pg.676]    [Pg.829]    [Pg.834]    [Pg.834]    [Pg.868]    [Pg.868]    [Pg.868]    [Pg.868]    [Pg.868]    [Pg.868]    [Pg.876]   
See also in sourсe #XX -- [ Pg.32 ]




SEARCH



Anti-nociceptive

Anti-nociceptive activity

Anti-nociceptive agents

Anti-nociceptive effects

Cannabinoids anti-nociceptive

Cardiac nociception

Inflammation pro-nociceptive prostaglandins

N-Ethylmaleimide-Induced Nociceptive Behavior Mediated Through Inhibition of Dynorphin Degradation

Neurotransmitters nociceptive afferent fibers

Nociception

Nociception ascending tracts

Nociception brain sites

Nociception dorsal horn

Nociception hyperalgesia

Nociception opioid receptor role

Nociception sleep

Nociception sodium channels

Nociception structures

Nociception, capsaicin effect

Nociception, definition

Nociceptive Behavior Induced by i.t.-Administered Prodynorphin-Derived Peptides and Polycationic Compounds

Nociceptive Transducers

Nociceptive nerve fibers

Nociceptive neuron

Nociceptive pain

Nociceptive pain, role

Nociceptive pathway

Nociceptive stimuli

Nociceptive synapse

Nociceptive threshold

P substance as pro-nociceptive

Pain and Nociception

Pro-nociceptive prostaglandins

Pro-nociceptive prostaglandins in inflammation

Pro-nociceptive transmitter release inhibition

Prostaglandin nociceptive effect

Thermal model of nociception

© 2024 chempedia.info